C. Robertson

发表

Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.

A. Luini, G. Viale, U. Veronesi, 1999, Journal of the National Cancer Institute.

Clinical validation of an autoantibody test for lung cancer

P. Boyle, J. Robertson, W. Wood, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Trends of oral cancer mortality among females worldwide

P. Boyle, G. Macfarlane, C. Scully, 1994, Cancer Causes & Control.

Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality

H. Klocker, P. Boyle, G. Severi, 2008, BJU international.

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria.

G Bartsch, H. Klocker, P. Boyle, 2001, Urology.

Screening for prostate cancer: updated experience from the tyrol study

H. Klocker, P. Boyle, G. Severi, 2005, The Canadian journal of urology.

473: Tyrolean Screening Study: Update 2005 - Stage Migration and Decrease of Mortality

H. Klocker, P. Boyle, G. Severi, 2006 .

Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women.

M. Cazzaniga, B. Bonanni, G. Pelosi, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women

M. Cazzaniga, B. Bonanni, S. Gandini, 2001, Breast Cancer Research and Treatment.

Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trial.

B. Bonanni, L. Baglietto, C. Robertson, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Hormonal Therapy and Chemoprevention

M. Cazzaniga, B. Bonanni, F. Pigatto, 2000, The breast journal.

Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy women.

B. Bonanni, S. Gandini, A. Barreca, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Meta-analysis of randomized trials of terazosin in the treatment of benign prostatic hyperplasia.

P. Boyle, C. Roehrborn, C. Robertson, 2002, Urology.

The prevalence of male urinary incontinence in four centres: the UREPIK study

L. Kiemeney, P. Boyle, F. Hobbs, 2003, BJU international.

Rationale for a study adding tamoxifen to HRT.

P. Boyle, G. D'aiuto, M. Pizzichetta, 2002, European journal of cancer.

Time course of fenretinide‐induced modulation of circulating insulin‐like growth factor (IGF)‐i, IGF‐II and IGFBP‐3 in a bladder cancer chemoprevention trial

A. Barreca, F. Pigatto, C. Robertson, 2000, International journal of cancer.

J. Hendry, B. O'Sullivan, G. Kerr, 1998, International journal of radiation oncology, biology, physics.

Phase III intermittent MAB vs continuous MAB.

Z. Kırkalı, A. Bono, M. Brausi, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Five years survival and risk of death in a phase III study of intermmittent monotherapy versus continuous combined androgen deprivation

J. Kliment, C. Robertson, P. Whelan, 2008 .

Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.

M. Cazzaniga, B. Bonanni, G. Pelosi, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radioguided Sentinel Node Biopsy to Avoid Axillary Dissection in Breast Cancer

A. Luini, M. Cremonesi, S. Zurrida, 2000, Annals of Surgical Oncology.

Finasteride in association with either flutamide or goserelin as combination hormonal therapy in patients with stage M1 carcinoma of the prostate gland

P. Boyle, K. Griffiths, R. Kirby, 1999, The Prostate.

Effect o f B lood T amoxifen C oncentrations o n S urrogate Biomarkers i n a T rial o f D ose R eduction i n H ealthy W omen

B. Bonanni, Alberto Costa, S. Gandini, 1999 .

Tamoxifen reduces plasma homocysteine levels in healthy women.

L. Baglietto, P. Mannucci, M. Cattaneo, 1998, British Journal of Cancer.

Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women.

P. Boyle, G. D'aiuto, M. Pizzichetta, 2003, Journal of the National Cancer Institute.

A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.

Umberto Veronesi, Paolo Veronesi, Giovanni Paganelli, 2003, The New England journal of medicine.

Need for global action for cancer control.

R. J. Thomas, H. Bartelink, A. Gavin, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Predicting non-organ-confined prostate cancer in men diagnosed after 2000

J. Moul, T. Polascik, C. Robertson, 2010, Prostate Cancer and Prostatic Diseases.

Beyond classical meta-analysis: can inadequately reported studies be included?

P. Boyle, C. Robertson, N. Idris, 2004, Drug discovery today.

Breast cancer incidence rates in Slovenia 1971-1993.

P. Boyle, M. Primic‐Žakelj, C. Robertson, 2000, International journal of epidemiology.

Decrease in prostate cancer mortality following introduction of prostate specific antigen (PSA) screening in the Federal State of Tyrol, Austria, 1993–1999

H. Klocker, P. Boyle, G. Severi, 2001 .

Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post‐operative sexual dysfunction

J. Moul, L. Gerber, L. Bañez, 2013, Andrology.

Age-period-cohort analysis of chronic disease rates. I: Modelling approach.

P. Boyle, C. Robertson, Chris Robertson, 1998, Statistics in medicine.

Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update.

M. Anscher, L. Prosnitz, C. Robertson, 1995, International journal of radiation oncology, biology, physics.

Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate

P. Febbo, J. Moul, D. Albala, 2006, Prostate Cancer and Prostatic Diseases.

The epidemiology of prostate cancer.

P. Boyle, G. Severi, L. Baglietto, 2003, The Urologic clinics of North America.

Variation within global cigarette brands in tar, nicotine, and certain nitrosamines: analytic study

D. Zaridze, P. Boyle, N. Gray, 2000, Tobacco control.

Rising trends of oral cancer mortality among males worldwide: the return of an old public health problem

P. Boyle, G. Macfarlane, C. Scully, 1994, Cancer Causes & Control.

Age-period-cohort models of chronic disease rates. II: Graphical approaches.

P. Boyle, C. Robertson, 1998, Statistics in medicine.

The association between induced and spontaneous abortion and risk of breast cancer in Slovenian women aged 25-54.

P. Boyle, T. Macfarlane, M. Primic‐Žakelj, 2001, Breast.

Effect of parity and age at delivery on breast cancer risk in Slovenian women aged 25–54 years

P. Boyle, C. Hsieh, M. Primic‐Žakelj, 1997, International journal of cancer.

Ocular effects of fenretinide, a vitamin A analog, in a chemoprevention trial of bladder cancer.

L. Baglietto, C. Robertson, A. Decensi, 2000, Cancer detection and prevention.

Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?

M Tubiana, P Maisonneuve, P. Boyle, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Double‐blind, placebo‐controlled trial to assess the efficacy and tolerability of mepartricin in the treatment of BPH

P. Boyle, C. Robertson, F. Pagano, 1998, The Prostate.

Analysis of tumor control probability (TCP) and normal tissue complication probability (NTCP) in 40 prostate cancer patients treated with 2 different techniques of 3D-conformal radiation therapy (3D-CRT)

M. Ghilezan, R. Orecchia, E. Negri, 1998 .

Efficacy of Vinblastine, Bleomycin, Methotrexate (VBM) Combination Chemotherapy with Involved Field Radiotherapy in Early Stage (I-IIA) Hodgkin Disease Patients

J. Bernier, G. Martinelli, R. Orecchia, 2003, Leukemia & lymphoma.

Meta-Analysis of Published Clinical Trials of a Ribosomal Vaccine (Ribomunyl®) in Prevention of Respiratory Infections

P. Boyle, J. Bellanti, C. Robertson, 2000, BioDrugs.

Characteristics of smokers' attitudes towards stopping: survey of 10,295 smokers in representative samples from 17 European countries

P. Boyle, K. Fagerström, S. Gandini, 2000 .

Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia.

P. Boyle, C. Roehrborn, C. Robertson, 2000, Urology.

Intermittent Androgen Deprivation for Locally Advanced Prostate Cancer

A. Bono, M. Brausi, C. Robertson, 2003, Oncology.

A method for estimating within-patient variability in maximal urinary flow rate adjusted for voided volume.

L. Kiemeney, A. Verbeek, J. J. de la Rosette, 2002, Urology.

The prevalence of urinary incontinence in community‐dwelling married women: a matter of definition

L. Kiemeney, P. Boyle, B. Bemelmans, 2004, BJU international.

Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy women.

B. Bonanni, A. Barreca, C. Robertson, 1999, European journal of cancer.

Preoperative chemotherapy in non-small-cell lung cancer: nothing new in N2 disease.

U. Pastorino, L. Spaggiari, F. D. De Braud, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Age at any birth and breast cancer risk.

P. Boyle, C. Robertson, 1998, Statistics in medicine.

Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin

F. D. De Braud, U. Veronesi, A. Siccardi, 1999, European Journal of Nuclear Medicine.

Breast cancer and colon cancer incidence in females in Scotland, 1960-84.

P. Boyle, C. Robertson, 1987, Journal of the National Cancer Institute.

Cancer mortality in Ireland, 1926-1995.

P. Boyle, P. Johnston, S. Golia, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Updated meta‐analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia

P. Boyle, C. Roehrborn, C. Robertson, 2004, BJU international.

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels.

A. Goldhirsch, G. Viale, M. Colleoni, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients.

P. Boyle, S. Gandini, H. Merzenich, 2000, European journal of cancer.

The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study

L. Kiemeney, P. Boyle, R. Hobbs, 2003, BJU international.

EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays

P. Boyle, J. Robertson, A. Murray, 2012, Tumor Biology.

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

P. Boyle, R. Rosen, R. Kirby, 2003, European urology.

Tamoxifen and Metabolite Concentrations in Serum and Breast Cancer Tissue during Three Dose Regimens in a Randomized Preoperative Trial

G. Pelosi, D. Serrano, F. Pigatto, 2004, Clinical Cancer Research.

Colorectal cancer follow-up: perspectives for future studies.

R. Audisio, C. Robertson, 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Application of a High Throughput Method of Biomarker Discovery to Improvement of the EarlyCDT®-Lung Test

J. Robertson, H. Sewell, A. Murray, 2012, PloS one.

Chemoprevention of breast cancer: The Italian experience

B. Bonanni, Alberto Costa, U. Veronesi, 2000, Journal of cellular biochemistry. Supplement.

Biologic activity of tamoxifen at low doses in healthy women.

B. Bonanni, P. Boyle, U. Veronesi, 1998, Journal of the National Cancer Institute.

Blood glucose concentrations and breast cancer risk in women without diabetes: a meta-analysis

P. Boyle, J. Rosenstock, P. Autier, 2013, European Journal of Nutrition.

Age, period and cohort models: the use of individual records.

P. Boyle, C. Robertson, 1986, Statistics in medicine.

Very young women (<35 years) with operable breast cancer: features of disease at presentation.

A. Luini, A. Goldhirsch, G. Viale, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Locally advanced and metastatic prostate cancer treated with intermittent androgen monotherapy or maximal androgen blockade: results from a randomised phase 3 study by the South European Uroncological Group.

J. Kliment, T. Oliver, C. Robertson, 2014, European urology.

Age-period-cohort models: a comparative study of available methodologies.

P. Boyle, S. Gandini, P Boyle, 1999, Journal of clinical epidemiology.

Larynx cancer in Slovakia and the role of anatomical subsites.

P. Boyle, G. Severi, I. Plesko, 1999, Oral oncology.

The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx.

P. Boyle, T. Wheldon, R. Symonds, 1993, European journal of cancer.

A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers.

A. Luini, M. Cazzaniga, G. Pelosi, 2003, Journal of the National Cancer Institute.

Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assay.

A. Goldhirsch, G. Viale, G. Curigliano, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

A Two-by-Two Factorial Trial Comparing Oral with Transdermal Estrogen Therapy and Fenretinide with Placebo on Breast Cancer Biomarkers

M. Cazzaniga, B. Bonanni, L. Baglietto, 2004, Clinical Cancer Research.

Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project

J. Coleman, H. Ahmed, L. Klotz, 2017, Prostate Cancer and Prostatic Diseases.

Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer.

G. Viale, U. Veronesi, P. Veronesi, 2001, European journal of cancer.

Breast carcinoma in elderly women

A. Luini, A. Goldhirsch, R. Audisio, 2004, Cancer.

Carcinoma of the Larynx

P. Boyle, C. Robertson, A. G. Robertson, 1987, Journal of surgical oncology.

Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project

J. Fütterer, P. Pinto, T. Reijke, 2015, World Journal of Urology.

Depression and degree of acceptance of adjuvant cytotoxic drugs

A. Goldhirsch, M. Mandalà, M. Colleoni, 2000, The Lancet.

Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center

Michael N. Ferrandino, J. Moul, S. Freedland, 2012, Prostate Cancer and Prostatic Diseases.

The Use of Carboplatin in Malignant Germ Cell Tumours

P. Boyle, B. Asselain, J. Bernier, 1994 .

The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study

L. Kiemeney, P. Boyle, F. Hobbs, 2003, BJU international.

The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studies

L. Kiemeney, P. Boyle, J. Mckinlay, 2007, BJU international.

Comparison of outcomes in women and men treated with coronary stent implantation

P. Boyle, D. Trabattoni, C. Robertson, 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group.

P. Boyle, G. Severi, U. Veronesi, 1998, British Journal of Cancer.

Mortality from cutaneous melanoma: evidence for contrasting trends between populations

P. Boyle, G. Severi, P. Autier, 2000, British Journal of Cancer.

Targeted screening for lung cancer with autoantibodies.

F. Mair, J. Haughney, D. Kendrick, 2021, medRxiv.

Phase II Trial of Vinorelbine, Cisplatin and Continuous Infusion of 5-Fluorouracil Followed by Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Cancer

F. D. De Braud, R. Orecchia, G. Catalano, 2002, Oncology.

Effect of Transdermal Estradiol and Oral Conjugated Estrogen on C-Reactive Protein in Retinoid-Placebo Trial in Healthy Women

M. Cazzaniga, B. Bonanni, S. Pecorelli, 2002, Circulation.

A meta‐analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia

P. Boyle, C. Robertson, E. Vaughan, 2004, BJU international.

INTERNATIONAL POPULATION-BASED STUDY OF UROLOGICAL CONDITIONS: THE UREPIK STUDY. II. COMPARATIVE PROSTATITIS DATA

L. Kiemeney, P. Boyle, M. Barry, 1999 .

Prediction of response to primary chemotherapy for operable breast cancer.

A. Goldhirsch, G. Viale, G. Viale, 1999, European journal of cancer.

Analysis of Irradiated Lung and Heart Volumes using Virtual Simulation in Postoperative Treatment of Stage I Breast Carcinoma

G. Severi, R. Orecchia, M. Intra, 2003, Tumori.

Maps and atlases of cancer mortality: a review of a useful tool to trigger new questions

P. Boyle, A. d’Onofrio, M. Boniol, 2016, Ecancermedicalscience.

A case-control study of lung cancer among Czech women.

P. Boyle, P. Zatloukal, S. Gandini, 2001, Lung cancer.

[Erectile dysfunction: prevalence and effect on the quality of life; Boxmeer study].

L. Kiemeney, P. Boyle, E. Meuleman, 2001, Nederlands tijdschrift voor geneeskunde.

Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.

A. Bono, M. Brausi, Chris Robertson, 2009, European urology.

Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: a linear quadratic analysis.

J. Dewar, H. Yosef, C. Robertson, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Trends in cancer mortality in central European countries--the effect of age birth cohort and time-period.

G. Macfarlane, C. Robertson, T. V. Evstifeeva, 1997 .

Interpretation and analysis of differential exposure variability and zero-exposure categories for continuous exposures.

P Maisonneuve, P. Boyle, G. Macfarlane, 1995, Epidemiology.

Update on tamoxifen to prevent breast cancer. The Italian Tamoxifen Prevention Study.

M. Cazzaniga, B. Bonanni, N. Rotmensz, 2000, European journal of cancer.

The effect of external events on a large double blind chemoprevention trial

P. Boyle, P. Maisonneuve, N. Rotmensz, 1998 .

Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency.

P. Boyle, C. Diehm, C. Robertson, 2003, International angiology : a journal of the International Union of Angiology.

Age-Period-Cohort Models: A Comparison of Methods

P. Boyle, C. Robertson, 1992 .

Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy

J. Moul, S. Freedland, F. Schroeck, 2008, Prostate Cancer and Prostatic Diseases.

Cancer mortality trends in the EU and acceding countries up to 2015.

B Møller, L J Schouten, C. la Vecchia, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of oral cancer: the need for defined protocols and specialist centres. variations in the treatment of oral cancer.

D. Soutar, P. McCarron, D. Hole, 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

Pretargeted adjuvant radioimmunotherapy with Yttrium-90-biotin in malignant glioma patients: A pilot study

P. Caliceti, C. Grana, G. Paganelli, 2002, British Journal of Cancer.

The relationship between lower urinary tract symptoms and health status: the UREPIK study

L. Kiemeney, P. Boyle, R. Hobbs, 2003, BJU international.

Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients

M. Ferrari, M. Cremonesi, C. Grana, 1999, European Journal of Nuclear Medicine.

The UrEpiK Study: A cross-sectional survey of benign prostatic hyperplasia, urinary incontinence and male erectile dysfunction, prostatitis and interstitial cystitis in the UK, France, the Netherlands and Korea

L. Kiemeney, P. Boyle, M. Barry, 1998 .

The prevalence of urinary incontinence in community-dwelling married women

L. Kiemeney, P. Boyle, C. Robertson, 2004 .

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women

P. Boyle, Alberto Costa, U. Veronesi, 1998, The Lancet.

Statistical modelling of breast cancer incidence and mortality rates in Scotland.

P. Boyle, C. Robertson, 1997, British Journal of Cancer.

Contribution of three components to individual cancer risk predicting breast cancer risk in Italy

S. Franceschi, P. Boyle, A. Decarli, 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels.

A. Goldhirsch, M. Colleoni, C. Robertson, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.

A. Bono, M. Brausi, C. Robertson, 2009, European urology.

Epidemiology of Prostate Cancer

Peter Boyle, Laura Baglietto, Sara Gandini, 2001, European Urology.

Screening for prostate cancer: Updated experience from the Tyrol study

H. Klocker, P. Boyle, G. Severi, 2004, Current urology reports.

Statistical modelling of lung cancer and laryngeal cancer incidence in Scotland, 1960-1979.

P. Boyle, C. Robertson, 1987, American Journal of Epidemiology.

Re: "Statistical modelling of lung cancer and laryngeal cancer incidence in Scotland, 1960-1979".

P. Boyle, C. Robertson, 1989, American Journal of Epidemiology.